Familial hypertrophic cardiomyopathy: Genes, mutations and animal models. A review;Cardiomiopatía hipertrófica familiar: Genes, mutaciones y modelos animales. Revisión

Investigacion Clinica

Volumn 45, Issue 1, 2004, Pages 69-100

  Ramírez, Carlos Darío ^a   Padrón, Raúl ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

Animal models; Genes; Hypertrophic cardiomyopathy; Mutations; Sarcomeric proteins

Indexed keywords

ALPHA ACTIN; ALPHA TROPOMYOSIN; CONNECTIN; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN; TROPONIN C; TROPONIN T; UNCLASSIFIED DRUG; ACTIN; CARDIAC MYOSIN; CARRIER PROTEIN; MUSCLE PROTEIN; MYH6 PROTEIN, HUMAN; MYOSIN; MYOSIN-BINDING PROTEIN C; PROTEIN KINASE; TPM1 PROTEIN, HUMAN; TROPOMYOSIN; TROPONIN; VENTRICULAR MYOSIN;

ALPHA MYOSIN HEAVY CHAIN GENE; BETA MYOSIN HEAVY CHAIN GENE; CLINICAL FEATURE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENE; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; HUMAN; MOLECULAR GENETICS; NONHUMAN; PATHOGENESIS; REVIEW; ANIMAL; DISEASE MODEL; FORECASTING; GENETICS; HYPERTROPHIC CARDIOMYOPATHY; MUTATION; TRANSGENIC ANIMAL;

ACTINS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CARDIAC MYOSINS; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; FORECASTING; HUMANS; MUSCLE PROTEINS; MUTATION; MYOSIN HEAVY CHAINS; MYOSINS; PROTEIN KINASES; TROPOMYOSIN; TROPONIN; VENTRICULAR MYOSINS;

EID: 16544395823     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (136)

1. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997; 33:775-785.
2. Richardson P, McKenna W, Bristow M, Maiseh B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the World Health Organization/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841-842.
3. Davies MJ, McKenna WJ. Hypertrophic cardiomyopathy: an introduction to pathology and pathogenesis. Br Heart J 1994; 72 (Suppl.):S2-S3.
4. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 1995; 92:785-789.
5. Malik MS, Watkins H. The molecular genetics of hypertrophic cardiomyopathy. Curr Opinion Cardiol 1997; 12:295-302.
6. Vulpian A. Contribution à l'étude des rétré cissements de l'orifice ventriculo-aortique. Arch Physiol 1868; 3:220-222.
7. Brock R. Functional obstruction of left ventricle (acquired subvalvular aortic stenosis). Guy's Hosp Rep 1957; 106: 221-238.
8. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 1958; 20:1-8.
9. Wigle D, Sasson Z, Handerson MA, Ruddy TD, Fulop J, Rakowski H, Williams WG. Hypertrophic cardiomyopathy: the importance of the site and the extent of hypertrophy. Prog Cardiovasc Dis 1985; 28:1-83.
10. Klues H, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by 2-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995; 26:1699-1708.
11. Maron BJ. Hypertrophic cardiomyopathy. Lancet 1997; 350:127-133.
12. Sharma S, Elliot PM, Whyte G, Mahon N, Virdeee M, McKenna WJ. Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophic in athletes. J Am Coll Cardiol 2000; 36:864-870.
13. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide range two-dimensional echocardiographic study of 125 patients. Am J Cardiol 1981; 48:418-428.
14. Varnava A, Baboonian C, Davison F, de la Cruz L, Elliott PM, Davies MJ, McKenna WJ. A new mutation of cardiac troponina T causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy. Heart 1999; 82:621-624.
15. McKenna WJ. The future in hypertrophic cardiomyopathy: important clues and potential advances from understanding of the genotype phenotype relationship. Ital Heart J 2000; 1:17-20.
16. Schwartz K, Carrier L, Guieheney P, Komadja M. Molecular basis of familial hypertrophic cardiomyopathy. Circulation 1995; 91:532-540.
17. Maron BJ, Moller JH, Seidman SE, Vincent GM, Dietz HC, Moss AJ, Towbin JA, Sondheimer HM, Pyeritz RE, McGee G, Epstein AE. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. Circulation 1998; 98:1460-1471.
18. Marian AJ, Roberts R. Recent advances in molecular genetics of hypertrophic cardiomyopathy. Circulation 1995; 92: 1336-1347.
19. Hagège AA, Dubourg O, Desnos M, Mirochnik R, Isnard G, Bonne G, Carrier L, Guieheney P, Bouhour JB, Schwartz K, Komajda M. Familial hypertrophic cardiomyopathy. Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy. Eur Heart J 1998; 19:490-499.
20. Fananapazir L, Epstein ND. Prevalence of hypertrophic cardiomyopathy: limitation of screening methods. Circulation 1995; 92:700-704.
21. Jarcho JA, McKenna WJ, Parc JA, Solomon SD, Holcombe RF, Dickie S, Levi T, Donis-Keller H, Seidman JG, Seidman CE. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med 1989; 321:372-378.
22. Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG. A molecular basis for familial hypertrophic cardiomyopathy: a beta-myosin heavy chain gene missense mutation. Cell 1990; 62:999-1006.
23. Watkins H, Mae Rae C, Thierfelder L, Chou YH, Frenneaux M, McKenna WJ, Seidman JG, Seidman CE. A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3. Nat Genet 1993; 3:333-337.
24. Hoffmann B, Schmidt-Traub H, Perrot A, Osterziel KJ, Geßner R. First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy. Hum Mutat 2001; 17:524.
25. Thierfelder L, Mae Rae C, Watkins H, Tomfohde J, Williams M, McKenna WJ, Bohm K, Nocske G, Schlepper M, Bowcock A, Vosberg HP, Seidman JG, Seidman CE. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc Natl Acad Sci USA 1993; 90:6270-6274.
26. Carrier L, Hengstenberg C, Beckmann, JS, Guieheney P, Dufour C, Bereovici J, Dausse E, Berebbi-Bertrand I, Wisnewsky C, Pulvenis D, Fetler L, Vignal A, Weissenbach J, Hillaire D, Feingold J, Bouhour JB, Hagège A, Desnos M, Isnard R, Dubourg O, Komajda M, Schwartz K. Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nat Genet 1993; 4:311-313.
27. Kimura A, Harada H, Park JE, Nishi H, Satoh M, Takahashi M, Hiroi S, Sasaoka T, Ohbuchi N, Nakamura T, Koyanagi T, Hwang TH, Choo JA, Chung KS, Hasegawa A, Nagai R, Okazaki O, Nakamura H, Matsuzaki M, Sakamoto T, Toshima H, Koga Y, Imaizumi T, Sasazuki T. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 1997; 16:379-382.
28. Poetter K, Jiang H, Hassanzadeh S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JR, Fananapazir L, Epstein ND. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 1996; 13: 63-69.
29. MaeRae CA, Ghaisas N, Kass S, Donnely S, Basson CT, Watkins HC, Anan R, Thierfelder LH, McGarry K, Rowland E, McKenna WJ, Seidman JG, Seidman CE. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest 1995; 96:1216-1220.
30. Mogensen J, Klausen IC, Pedersen AK, Eglebad H, Bross P, Kruse TA, Gregersen N, Hansen PS, Baandrup U, Borglum AD. Alpha-cardiac actin is a novel disease gene in hypertrophic cardiomyopathy. J. Clin Invest 1999; 103:R39-R43.
31. Satoh M, Takahashi M, Sakamoto T, Hiroe M, Marumo F, Kimura A. Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem Biophys Res Commun 1999;262:411-417.
32. Coueke PJ, Van Hauwe P, Kelley PM, Kunst H, Schatteman I, Van Velzen D, Meyers J, Ensink RJ, Verstreken M, Deelau F, Marres H, Kastury K, Bhasin S, McGuirt WT, Smith RJH, Cremers CWRJ, Van de Heyning P, Willems PJ, Smith SD, Van Camp G. Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum Molec Genet 1999; 8:1321-1328.
33. Gollob MH, Green, MS, Tang AS-L, Gollob T, Karibe A, Al Sayegh AH, Ahmad F, Lozado R, Shah G, Fananapazir L, Bachinski LL, Roberts R. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Eng J. Med 2001; 344:1823-1831.
34. Takeda N. Cardiomyopathies and mitochondrial DNA mutations. Mol Cell Biochem 1997; 176:287-290.
35. Marian AJ. Modifier genes for hypertrophic cardiomyopathy. Curr Opin Cardiol 2002; 17:242-202.
36. rd Ed. McGraw-Hill.
37. Rayment I, Rypniewski WR, Schmidt-Bäse K, Smith R, Tomehick DR, Benning MM, Winkelmann DA, Wesenberg G, Holden HM. Three-dimensional structure of myosin subfragment-1: a molecular motor. Science 1993; 261:50-56.
38. Schiaffino S, Reggiani C. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev 1996; 76:371-423.
39. Padrón R, Alamo L, Murgieh J, Craig R. Towards an atomic model of the thick filaments of muscle. J Mol Biol 1998; 275: 35-41.
40. Flavigny J, Richard P, Isnard R, Carier L, Charron P, Bonne G, Forissier J-F, Desnos M, Dubourg O, komajda M, Schwartz K, Hainque B. Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy. J Mol Med 1998; 76:208-214.
41. 2+ binding, and phosphorylation. J Biol Chem 2001; 276:7086-7092.
42. Morano I. Tuning the human heart molecular motors by myosin light chains. J. Mol. Med 1999; 77:544-555.
43. Sweeney HL, Bowman BF, Stull J. Myosin light chain phosphorylation in vertebrate striated muscle: regulation and function. Am J Physiol 1993; 264:C1085-C1095.
44. 2+ sensitive tension due a partial extraction of C-protein from rat skinned cardiac myocytes and rabbit skeletal muscle fibers. J Gen Physiol 1991; 97: 1141-1163.
45. Weisberg A, Winegrad S. Alteration of myosin cross bridges by phosphorylation of myosin-binding protein C in cardiac muscle. Proc Natl Acad Sci USA 1996; 93:8999-9003.
46. Dennis JE, Shimizu T, Reinach FC, Fischman DA. Localization of C-protein isoforms in chicken skeletal muscle: ultrastructure detection using monoclonal antibodies. J Cell Biol 1984; 98: 1514-1522.
47. Mereadier JJ, Bouveret P, Gorza L, Schiaffino S, Clark WA, Zak R, Swynghedauw B, Svhwartz K. Myosin isoenzymes in normal and hypertrophied human myocardium. Circ Res 1983; 53:52-62.
48. Jacnicke T, Diederich MV, Haas W, Schleigh J, Lichter P, Pfordt Bach A, Vosberg HP. The complete sequence of the human beta-myosin heavy chain and a comparative analysis of its product. Genomics 1990; 8:194-206.
49. Miyata S, Minobe W, Briston MR, Leinwald LA. Myosin heavy chain isoform expression in the failling and nonfailling human heart. Circ Res 2000; 86:386-390.
50. Nakao K, Minobe W, Roden R, Briston MR, Leinwald LA. Myosin heavy chain expression in human heart failure. J Clin Invest 1997; 100:2362-2370.
51. Watkins H, Rosenzweig A, Hwang DS, Levi T, McKenna W, Seidman CE, Seidman JG. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992; 326: 1108-1114.
52. Dausse E, Komajda M, Dubourg O, Fetler L, Dufour C, Carrier L, Wisnewsky C, Bereovici J, Hengstenberg C, Al-Mahdawi S, Isnard R, Hagège A, Bouhour JB, Desnos M, Beckmann JS, Weissenbach J, Schwartz K, Guieheney P. Familial hypertrophic cardiomyopathy: microsatellite haplotyping and identification of a hot-spot for mutations in β-myosin heavy chain gene. J Clin Invest 1993; 92: 2807-2813.
53. Fananapazir L, Dalakas MD, Cyran F, Cohn G, Epstein ND. Misssense mutations in the β myosin heavy chain gene cause central core disease in hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 1993; 90:3993-3997.
54. Nakajima-Taniguchi C, Matsui H, Eguchi N, Nagata S, Kishimoto T, Yamauchi-Takihara K. A novel deletion mutation in the β-myosin heavy chain gene found in Japanese patients with hypertrophic cardiomyopathy. J Mol Cell Cardiol 1995; 27:2607-2612.
55. Charron P, Carrier L, Dubourg O, Tesson F, Desnos M, Richard P, Bonne G, Guieheney P, Hainque B, Bouhour J, Mallet A, Feingold J, Schwartz K, Komajda M. Penetrance of familial hypertrophic cardiomyopathy. Genet Courts 1997; 8:107-114.
56. Marian AJ, Yu QT, Mares A, Hill R, Roberts R, Perryman MB. Detection of a new mutation in the β myosin heavy chain in an individual with hypertrophic cardiomyopathy. J Clin Invest 1992; 90:2156-2165.
57. Nishi H, Kimura A, Matsuyama K, Koga Y, Sasazuki T, Toshima H. Two distinct mutations of cardiac β myosin heavy chain gene found in a Japanese patient with hypertrophic cardiomyopathy. Circulation 1993; 88 (suppl. 1):1-343.
58. Rayment I, Holden HM, Sellers JR, Fananapazir L, Epstein ND. Structural interpretation of the mutations in the β-cardiac myosin that have implicated in the familial hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 1995; 92:3864-3868.
59. Epp TA, Dixon IMC, Wang H-Y, Sole M, Liew C-C. Structural organization of the human cardiac alpha-myosin heavy chain gene (MYH6). Genomics 1993; 18: 505-509.
60. Niimura H, Patton KK, McKenna WJ, Soults J, Maron BJ, Seidman JG, Seidman CE. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 2002; 105:446-451.
61. Eden D, Highsmith S. Light chain-dependent by transient electrical birefringence. Biophys J 1997; 73:958-972.
62. Epstein D. The molecular biology and pathophysiology of hypertrophic cardiomyopathy due to mutations in the beta myosin heavy chains and the essential and regulatory light chains. Adv Exp Med Biol 1998; 453:105-115.
63. Andersen PS, Havndrup O, Bungaard H, Moolman-Smook, JC, Larsen LA, Mogensen J, Brink PA, Børglum AD, Corfield VA, Kjeldsen K, Vuust J, Christiansen M. Myosin light chain mutations in familial hypertrophic cardiomyopathy: phenotypic presentation and frequency in Danish and South African populations. J Med Genet 2001; 38:E43.
64. Ikebe M, Reardon S, Sehwonek JP, Sanders CR, Ikebe R. Structural requirement of the regulatory light chain of smooth muscle myosin as a substrate for myosin light chain kinase. J Biol Chem 1994; 269:28165-28172.
65. Trybus KM, Waller GS, Chatman TA. Coupling of ATPase activity and motility in smooth muscle myosin is mediated by the regulatory light chain. J Biol Chem 1994; 124:963-969.
66. Vemuri R, Lankford EB, Poetter K, Hassanzadeh S, Takeda K, Yu ZX, Ferrans VJ, Epstein ND. The stretch-activation response may be critical to the proper functioning of the mammalian heart. Proc Natl Acad Sci USA 1999; 274:1048-1053.
67. Anderson AAW, Greig A, Mark TM, Malouf NN, Oakeley AE, Ungerleider RM, Allen PD, Kay BK. Molecular basis of human cardiac troponin T isoforms in the developing, adult, and mailing Herat. Circ Res 1995; 76:681-686.
68. Mesnard L, Logeart D, Taviaux S, Diriong S, Mereadier JJ, Samson F. Human cardiac troponin T: cloning and expression of new isoforms in the normal and failing heart. Circ Res 1995; 76:687-692.
69. Townsend P, Barton P, Yacoub M, Farza HI. Molecular cloning of human cardiac troponin T isoforms: expression in developing and failing heart. J Mol Cell Cardiol 1995; 27:2223-2236.
70. Townsend P, Farza HI, MacGeoch C, Spurr NK, Wade R, Gahlmann R, Yacoub MH, Barton PJR. Human cardiac troponin T: identification of fetal isoforms and assignment of the TNNT2 locus to chromosome 1q. Genomics 1994; 21:311-316.
71. Jing P, Huang QQ, Yeh HI, Lin JJC. Complete nucleotide sequence and structural organization of rat cardiac troponin gene: a single gene generates embryonic and adult isoforms via developmentally regulated alternative splicing. J Mol Biol 1992; 227:1269-1276.
72. Thierfielder L, Watkins H, MaeRae C, Limas R, McKenna W, Vosberg HP, Seidman JC, Seidman CE. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994; 77:701-712.
73. Forissier JF, Carrier L, Farza H, Bonne G, Bereovici, J, Richard P, Hainque B, Townsend PJ, Yacoub MH, Fauré S, Dubourg O, Millaire A, Hagège A, Desnos M, Komajda M, Schwartz K. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation 1996; 94:3069-3073.
74. Zot AS, Potter JD. Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction. Ann Rev Biophys Biophys Chem 1987; 16:535-559.
75. Perry SV. Troponin. Genetics, properties and function. J Muscle Res Cell Motil 1998; 19:575-602.
76. Watkins HI, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O' Donohue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, Seidman CE. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995; 332: 1058-1064.
77. Anan R, Shono H, Kisanuki A, Arima S, Nakao S, Tanaka H. Patients with familial hypertrophic cardiomyopathy caused by a Phc110Ilc missense mutation in the cardiac troponin T gene have variable cardiac morphologics and a favorable prognosis. Circulation 1998; 98:391-397.
78. Elliot PM, D' Cruz L, McKenna WJ. Late-onset hypertrophic cardiomyopathy caused by a mutation in the cardiac troponin gene. N Engl J Med 1999; 341:1855-1856.
79. Solaro RJ, Van Eyk J. Altered interactions among thin filament proteins modulates cardiac function. J Mol Cell Cardiol 1996; 28:217-230.
80. 2+ sensitivity of rat myofibrils. J Biol Chem 1997; 272:26887-26892.
81. Yamauchi-Takihara K, Nakajima-Taniguchi C, Matsui H, Fujio Y, Kunisada K, Nagata S, Kishimoto T. Clinical implications of hypertrophic cardiomyopathy associated with mutations in the alpha-tropomyosin gene. Heart 1996; 76:63-65.
82. Nakajima-Taniguchi C, Matsui H, Nagata S, Kishimoto T, Yamauchi-Takihara K. Novel missense mutation in the alpha-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy. J Mol Cell Cardiol 1995; 27: 2053-2058.
83. Bottinelli R, Coviello DA, Redwood CS, Pellegrino MA, Maron BJ, Spirito P, Watkins H, Reggiani C. A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Circ Res 1998; 82:106-115.
84. Karibe A, Tobaeman LS, Strand J, Butters C, Back N, Bachinski LL, Arai AE, Ortiz A, Roberts R, Homsher E, Fananapazir L. Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis. Circulation 2001; 103:65-71.
85. Bonne G, Carrier L, Bereoviei J, Cruaud C, Richard P, Hainque B, Gautel M, Labeit S, James M, Beckman JS, Weissenbach J, Vosberg HP, Fiszman M, Komajda M, Schwartz K. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 1995; 11:438-440.
86. Gautel M, Zuffardi O, Freiburg A, Labeit S. Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction? EMBO J 1995; 14:1952-1960.
87. Carrier L, Bonne G, Bährend E, Yu B, Richard P, Niel F, Hainque B, Cruaud C, Gary F, Labeit S, Bouhour JB, Dubourg O, Desnos M, Hagège AA, Trent RJ, Komajda M, Schwartz K. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res 1997; 80:427-434.
88. Einheber S, Fischman DA. Isolation and characterization of a cDNA clone encoding avian skeletal muscle C-protein: an intracellular member of of the immunoglobulin superfamily. Proc Natl Acad Sci USA 1990; 87:2157-2161.
89. Watkins H, Conner D, Thierfelder L, Jarcho JA, MaeRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 1995; 11:434-437.
90. Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna WJ, Kristinsson A, Roberts R, Sole M, Maron BJ, Seidman JG, Seidman CE. Mutations in the gene for cardiac myosin-binding proton C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 1998; 338:1248-1257.
91. Charron P, Dubourg O, Desnos M, Bennaeeur M, Carrier L, Camproux AC, Isnard R, Hagège A, Langlard JM, Bonne G, Richard P, Hainque B, Bouhour JB, Schwartz K, Komajda M. Clinical features and prognostic implications of familial hypertropic cardiomyopathy related to the cardiac myosin-binding protein C. Circulation 1998; 97:2230-2236.
92. St. Martin JS, Epstein JA. Hypertrophic cardiomyopathy: beyond the sarcomere. N Engl J Med 1998; 338:1303-1304.
93. Hamada H, Petrino MG, Kakunaga T. Molecular structure and evolutionary origin of human cardiac muscle actin gene. Proc Natl Acad Sci USA 1982; 79:5901-5905.
94. Shows T, Eddy RL, Haley L, Byers M, Henry M, Gunning P, Ponte P, Kedes L. The coexpressed genes for human alpha (ACTA) and cardiac actin (ACTC) are on chromosomes 1 and 15, respectively. Cytogenet Cell Genet 1984; 37:583.
95. Olson TM, Doan TP, Kishimoto NY, Whitby FG, Ackerman MJ, Fananapazir L. Inherited and the novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. J Mol Cell Cardiol 2000; 32:1687-1694.
96. Pelin K, Ridanpaa M, Donner K, Wilton S, Krishnarajah J, Laing N, Kolmerer B, Millevoi S, Labeit S, de la Chapelle A, Wallgren-Pettersson C. Refined localization of the genes for nebulin and titin on chromosome 2q allows the assignment of nebulin as a candidate, for autosomal recessive nemalyne myopathy. Europ J Hum Genet 1997; 5:229-234.
97. Labeit S, Kolmerer B. Titins: giant proteins in charge of muscle ultrastructure and elasticity. Science 1995; 270:293-296.
98. Freiburg A, Gautel M. A molecular map of the interactions between titin and myosin binding protein C. Implications for sarcomérica assembly in familial hypertrophic cardiomyopathy. Eur J Biochem 1996; 235:317-323.
99. Geisterfer-Lowranee A, Christie ME, Giewat M, Conner DA, Ingwall JS, Shoen FJ, Seidman CE, Seidman JG. A mouse model of familial hypertrophic cardiomyopathy. Science 1996; 272:731-734.
100. Fatkin D, Christie ME, Aristizabal O, McDonnelll BK, Srinivasan S, Schoen FJ, Seidman CE, Turnbull DH, Seidman JG. Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene. J Clin Invest 1999; 103:147-153.
101. Georgakopoulus D, Christie ME, Giewat M, Seidman CM, Seidman JG, Kass DA. The pathogenesis of familial hypertrophic cardiomyopathy: early and evolving effects fron an alpha-cardiac myosin heavy chain missense mutation. Nat Med 1999; 5: 327-330.
102. Kim SJ, Iizuka K, Kelly RA, Geng YJ, Bishop SP, Yang G, Kudej A, McDonell BK, Seidman CE, Seidman JG, Vatner SF. An alpha-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes. Am J Physiol 1999; 276:H1780-1787.
103. Spindler M, Saupe KW, Christie ME, Sweeney HL, Seidman CM, Seidman JG, Ingwall JS. Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. J Clin Invest 1998; 101:1775-1783.
104. Tyska MJ, Hayes E, Giewat M, Seidman CE, Seidman JG, Warshaw DM. Single-molecule mechanics or R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. Circ Res 2000; 86:737-744.
105. Blanchard E, Seidman CE, Seidman G, LeWinter M, Maughan D. Altered crossbridge kinetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. Circ Res 1999; 84:475-483.
106. Vemuri R, Lankford EB, Poetter K, Hassanzadeh S, Takeda K, Yu ZX, Ferrans VJ, Epstein ND. The stretch-activation response may be critical to the proper functioning of the mammalian heart. Proc Natl Acad Sci USA 1999; 96:1048-1053.
107. Sanbe A, Fewell JG, Gulick J, Osinka H, Lorenz J, Hall DG, Murray LA, Kimball TR, Witt SA, Robbins J. Abnormal cardiac structure and function in mice expressing nonphosphorylatable cardiac regulatory myosin light chain 2. J Biol Chem 1999; 274:21085-21094.
108. Sanbe A, Nelson D, Gulik J, Setzer E, Osinka H, Wang X, Hewett TE, Klevitsky R, Hayes E, Warshaw DM, Robbins J. In vivo analysis of an essential myosin light chain mutation linked to familial hypertrophic cardiomyopathy. Circ Res 2000; 87:296-302.
109. James J, Zhang Y, Wright K, Witt S, Glaseoek E, Osinka H, Klevitsky R, Martin L, Yager K, Sanbe A, Robbins J. Transgenic rabbits expressing mutant essential light chain do not develop hypertrophic cardiomyopathy. J Mol Cell Cardiol 2002; 34:873-882.
110. Yang Q, Sanbe A, Osinka H, Hewett TE, Klevitsky R, Robbins J. A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy. J Clin Invest 1998; 102:1292-1300.
111. Yang Q, Sanbe A, Osinka H, Hewett TE, Klevitsky R, Robbins J. In vivo modeling of myosin-binding protein C human familial hypertrophic cardiomyopathy. Circ Res 1999; 85:841-847.
112. Harris SP, Bartley CR, Hacker TA, McDonald KS, Douglas PS, Greaser ML, Powers PA, Moss RL. Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice. Circ Res 2002; 90:594-601.
113. Dalloz F, Osinka H, Robbins J. Manipulating the contractile apparatus: genetically defined animal models of cardiovascular diseases. J Mol Cell Cardiol 2001; 33:9-25.
114. Muthuchamy M, Pieples K, Rethinasamy P, Hoit B, Grupp, IL, Boivin GP, Wolska B, Evans C, Solaro RJ, Wicezorek DF. Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction. Circ Res 1999; 85:47-56.
115. Bottinelli R, Covielo DA, Redwood CS, Pellegrino MA, Maron BJ, Spirito P, Watkins H, Reggiani C. A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Circ Res 1998; 82:106-115.
116. Blanchard EM, Irizuka K, Christie M, Conner DA, Geisterfer-Lowranee A, Schoen FJ, Maughan DW, Seiman CE, Seidman JG. Targeted ablation of the murine alpha-tropomyosin gene. Circ Res 1997; 81:1005-1010.
117. Rethinasamy P, Muthuchamy M, Hewett T, Boivin G, Wolska BM, Evans C, Solaro RJ, Wicezorek DF. Molecular and physiological effects of alpha-tropomyosin ablation in the mouse. Circ Res 1998; 82:116-123.
118. Bing W, Knott A, Redwood C, Esposito, G, Purcell I, Watkins H, Maston S. Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha-tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay. J Mol Cell Cardiol 2000; 32: 1489-1498.
119. Oberts L, Zhao G, Park JT, Brugada R, Michael LH, Entman ML, Roberts R, Marian AJ. Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice. J Clin Invest 1998; 102:1498-1505.
120. Lim DS, Oberst L, McCluggage M, Younker K, Lacy J, DeMayo F, Entman ML, Roberts R, Michael LH, Marian AJ. Decreased left ventricular ejection fraction in transgenic mice expressing mutant cardiac troponin T-q(92), responsible for human hypertrophic cardiomyopathy. J Mol Cell Cardiol 2000; 32:365-374.
121. Yu Q, Zhao G, Marian AJ. In vivo short-term expression of a hypertrophic cardiomyopathy mutation in adult rabbit myocardium: myofibrillar incorporation without early disarray. Proc Assoc Am Physicians 1999; 104:469-481.
122. Elliot K, Watkins H, Redwood CS. Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy. J Biol Chem 2000; 275:22069-22074.
123. James J, Zhang Y, Osinka H, Sanbe A, Klevitsky R, Hewett TE, Robbins J. Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy. Circ Res 2000; 87: 805-811.
124. Nagueh SF, Baehinski L, Meyer D, Hill R, Zoghbi WA, Tam JW, Quiñones MA, Roberts R, Marian AJ. Tissue Doppler imaging consistently detects myocardium abnormalities in patients with familial hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 2001; 104:128-130.
125. Lankford EB, Epstein ND, Fananapazir L, Sweeney HL. Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest 1995; 95:1409-1414.
126. Malinchik S, Cuda G, Podolsky RJ, Horowits R. Isometric tension and mutant myosin heavy chain content in single skeletal myofibers from hypertrophic patients. J Mol Cell Cardiol 1997; 29:667-676.
127. Marian AJ. Pathogenesis of diverse, clinical and pathological phenotypes in hypertrophic cardiomyopathy. Lancet 2000; 355:58-60.
128. Lim DS, Lutucuta S, Bachireddy P, Younker K, Evans A, Entman M, Roberts R, Marian AJ. Angiotensin II blockade reverses myocardial fibrosis in transgenic mouse model of human hypertrophic cardiomyopathy. Circulation 2001; 103:789-791.
129. Oi S, Haneda T, Osaki J, Kashiwagi Y, Nakamura Y, Kawabe J, Kikuchi K. Lovastin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat Herat cells. Eur J Pharmacol 1999; 34:439-444.
130. Su SF, Hsiao CL, Chu CW, Lee BC, Lee TM. Effects of pravastatin on left ventricular mass in patients with hyperlipidemia and essential hypertension. Am J Cardiol 2000; 86:514-518.
131. Patel R, Nagueh SF, Tsybouleva N, Abdellatiff M, Lutucuta S, Kopelen HA, Quiñones MA, Zoghbi WA, Entman ML. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation 2001; 104:317-324.
132. Arad M, Seidman JG, Seidman CE. Phenotypic diversity in hypertrophic cardiomyopathy. Hum Mol Genet 2002; 11:2499-2506.
133. Towbin JA, Bowles NE. The failing heart. Nature 2002; 415:227-233.
134. Offer G. and Knight P. The structure of the head-tail junction of the myosin molecule. J Mol Biol 1996; 256:407-416.
135. Offer G, Knight P, Burgess SA, Álamo L, Padrón, R. A new model for the surface arrangement of myosin molecules in heads in tarantula thick filaments. J Mol Biol 2000; 298:239-260.
136. Marti-Renon MA, Stuart A, Fiser A, Sánchez R, Melo F, Sali A. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 2000; 29:291-325.